Trial NCT01369199

View at ClinicalTrials.gov 
Aliases: NCT01534611
Org. Study IDs: DK082864 HBRN IT Adult Trial
Secondary IDs: A-DK-3002-001 M01RR000040 P30DK050306 U01DK082843 U01DK082863 U01DK082864 U01DK082866 U01DK082867 U01DK082871 U01DK082872 U01DK082874 U01DK082916 U01DK082919 U01DK082923 U01DK082927 U01DK082943 U01DK082944 UL1RR024986 UL1TR000004 UL1TR000058 UL1TR001111

Last trial update was posted on 2022-05-26

MeSH Interventions

Entecavir Peginterferon alfa-2a

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Early termination of recruitment per Data and Safety Monitoring Board. 1 case with multiple central and local lab discrepancies was not considered to have HBeAg loss since central lab was always negative.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID